scholarly article | Q13442814 |
P50 | author | Unal Egeli | Q48345246 |
P2093 | author name string | Berrin Tunca | |
Gulsah Cecener | |||
Ismet Tasdelen | |||
P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
Evidence of founder mutations in Finnish BRCA1 and BRCA2 families | Q24538977 | ||
Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families | Q24644237 | ||
Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status | Q24802534 | ||
Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA) | Q24802704 | ||
BRCA2 mutation carriers, reproductive factors and breast cancer risk | Q24803237 | ||
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews | Q28387376 | ||
Identification of the breast cancer susceptibility gene BRCA2 | Q29616290 | ||
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families | Q33182519 | ||
A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland | Q33680801 | ||
An unaffected individual from a breast/ovarian cancer family with germline mutations in both BRCA1 and BRCA2. | Q33873257 | ||
Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed | Q34141317 | ||
Low incidence of BRCA2 mutations in breast carcinoma and other cancers | Q34381064 | ||
BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients | Q36621949 | ||
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds | Q41226231 | ||
A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes | Q42640148 | ||
Germline BRCA1 mutations in Iranian women with breast cancer. | Q43542131 | ||
Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations | Q47595985 | ||
BRCA1 mutations in primary breast and ovarian carcinomas | Q48078473 | ||
Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study. | Q54765466 | ||
Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2Mutation | Q57250729 | ||
Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes | Q57274836 | ||
BRCA2 arg372hispolymorphism and epithelial ovarian cancer risk | Q57306056 | ||
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes | Q57309394 | ||
P433 | issue | 5 | |
P921 | main subject | ovarian cancer | Q172341 |
P304 | page(s) | 484-491 | |
P577 | publication date | 2006-08-01 | |
P1433 | published in | Cancer Investigation | Q325953 |
P1476 | title | Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives | |
P478 | volume | 24 |